AXT, Inc. research snapshot
AXTI AI stock analysis reads AXT Inc. as a high-growth specialty semiconductor materials supplier that reached an operating inflection point in Q2 2026. Revenue jumped 164.8% year over year to $47.6 million with record indium phosphide sales, GAAP gross margin expanded to 44.9%, and the company swung to a GAAP net profit of $11.1 million. Management guided Q3 revenue to about $66 million with non-GAAP EPS of $0.30 to $0.32, far above consensus, and reported a backlog above $100 million plus long-term supply agreements with Coherent, Lumentum, and Casela. At the August 3, 2026 data cutoff, AXTI closed near $68.67 with a market capitalization near $4.49 billion. The stock is still about 52% below its 52-week high of $143.16 and trades near 36 times trailing revenue, so valuation, China exposure, and export permit risk remain central. This page uses scenario ranges and source checks, not a certain stock price prediction, and is for informational use only.
Current price
$68.67
Market cap
$4.49 billion
AI score
68 / 100
Rating
High-growth AI infrastructure materials play, now GAAP profitable, priced for aggressive expansion
Trend status
Sharp three-session post-earnings rally to $68.67, still about 52% below the $143.16 high with extreme volatility
Data cutoff (updated monthly)
August 4, 2026
Informational use only. This page is not investment advice.
| Dimension | Conclusion | Confidence |
|---|---|---|
| Business quality | AXT grows indium phosphide, gallium arsenide, and germanium substrates used in AI data center optical transceivers, 5G, LiDAR, and satellite solar cells. InP is now central to 800G and 1.6T optical links, and Q2 InP revenue hit a company record of $30.7 million. The niche is high growth with improving pricing power. | Medium |
| Moat | The moat comes from crystal growth know-how, multi-year customer qualification cycles, an integrated supply chain with ten partially owned Chinese raw-material companies, and an estimated 40% share of InP substrates. Competition from Sumitomo, JX Nippon, and Chinese entrants remains the main threat, and the 2027 capacity plan aims to make AXT the largest InP producer. | Low-medium |
| Management | Founder-CEO Morris Young has led AXT since 1986. Recent decisions include an April 2026 equity raise with about $632 million gross proceeds, long-term supply deals with Coherent, Lumentum, and Casela, and a plan to roughly triple quarterly InP revenue capacity by the end of 2026 and double it again in 2027. The execution track record is short and the raise added about 50% more shares. | Medium |
| Financial trend | Strong recent inflection. Q2 2026 revenue of $47.6 million rose 164.8% year over year, GAAP gross margin hit 44.9%, and GAAP net income attributable to AXT was $11.1 million, or $0.17 per diluted share. TTM revenue reached $125.5 million. Q3 guidance of about $66 million revenue with non-GAAP EPS of $0.30 to $0.32 is well above consensus. | Medium |
| Valuation | At $68.67, AXTI trades near 36 times trailing revenue and roughly 4.5 times book value. TTM P/E is not meaningful because trailing EPS is near zero. The stock is still about 52% below its 52-week high, and the price implies a fast, sustained profit ramp. | Medium |
| Technical trend | Strong post-earnings momentum. After falling about 74% from the $143.16 high to the high-$30s in late July, AXTI rallied roughly 27%, 29%, and 14% over the three sessions through August 3 to $68.67 on heavy volume. The stock remains below its high and is still in a volatile recovery structure. | Medium |
| Risk level | High. Key risks are China exposure and US export permits for InP substrates, heavy reliance on a China-based supply chain, roughly 50% more shares outstanding than a year ago from the April equity raise, demand cyclicality, InP competition, extreme small-cap volatility with beta near 1.9, and a still-demanding valuation. | Medium |
| AI confidence | Medium-high on reported financials and quote data; medium-low on forward capacity and margin trajectory. | Medium data confidence |
| Investment certainty | Low to medium. The page frames scenarios and monitoring rules, not a buy or sell instruction. AXTI suits only aggressive, high-risk-tolerant investors. | Low |
AXTI AI stock forecast
The AXTI AI stock forecast uses scenario ranges around the August 3, 2026 close of $68.67 and the company Q3 2026 guidance of about $66 million revenue with non-GAAP EPS of $0.30 to $0.32. The framework weights revenue ramp, gross margin, and execution of the capacity expansion rather than a single price target. The bull case requires InP demand to keep outstripping supply, export permits to clear, and margins to hold near 45%. The bear case materializes if demand slows, permits disrupt shipments, competition erodes pricing, or the capacity ramp disappoints.
$110 to $140
More likely if Q3 revenue lands at or above the $66 million guide, InP demand stays ahead of supply through 2027, gross margin holds above 40%, and additional export permits unlock upside. This range sits around and above the $125 Northland target and below the $143.16 high.
$70 to $100
More likely if AXT keeps executing sequential growth and profitability through 2026 but the multiple compresses as the growth rate normalizes. This range brackets the analyst consensus near $91 and the Needham and Wedbush targets of $90 to $93.
$35 to $55
More likely if export permits delay shipments, InP pricing erodes under competition, capacity expansion slips, or demand decelerates. This range retests the late-July low near $37 and the $55 B. Riley target.
AXTI AI technical analysis
AXTI AI technical analysis is based on the August 3, 2026 close of $68.67. The stock drew down about 74% from its $143.16 high to the high-$30s in late July, then reversed sharply after the Q2 beat, closing up roughly 27%, 29%, and 14% across three sessions to $68.67 with volume of 17.6 million shares against an average near 9.9 million. Levels below are approximate because the name trades with very wide daily ranges.
| Level | Value | Why it matters |
|---|---|---|
| Current price | $68.67 | Close of August 3, 2026 after a +13.64% session; after-hours trading printed near $71. The daily range that day spanned $53.66 to $71.21. |
| Near support | $55 to $57 | The gap-up zone from the earnings reaction and the August 3 intraday low of $53.66. A close below $55 would suggest the post-earnings pop is losing steam. |
| Deeper support | $47 to $50 | The post-earnings reaction level near $46.94 printed on July 30, 2026 after the Q2 release. This marks the breakout base for the current rally. |
| Major support | $35 to $40 | The late-July pre-earnings low area near $37, which was the low of the correction off the January high. |
| Near resistance | $70 to $72 | The August 3 intraday and after-hours highs near $71. A decisive close above this level would confirm the recovery continues. |
| Next resistance | $90 to $93 | The Needham and Wedbush price targets of $90 and $93. This zone represents the next structural resistance after the August rebound. |
| 52-week high | $143.16 | Reached in early 2026 during peak InP enthusiasm. The stock is about 52% below this level and it remains the reference for a full recovery scenario. |
| Momentum | Strong short-term, from a broken downtrend | Three consecutive double-digit gains after Q2 earnings with volume about 1.8 times the average. Long-term momentum is still below the January peak. |
| Volume | 17.6 million shares on August 3 versus an average near 9.9 million | Elevated volume confirms institutional and retail participation in the reversal. |
| Volatility | Beta near 1.9, 52-week range of $1.90 to $143.16 | Daily ranges of 10-15% are common. Position sizing must account for extreme swings. |
| Invalidation | Weekly close back below $47 | A sustained break below the July 30 earnings reaction level would invalidate the reversal and open a retest of the $35 to $40 zone. |
AXTI AI trading strategy
The AXTI AI trading strategy is a rules-based framework for a newly profitable, high-volatility semiconductor materials stock. It is not personal advice. Pair it with fresh charts, filings, export permit news, and position sizing that can absorb 40-50% drawdowns. The late October Q3 2026 earnings release and quarterly capacity updates are the near-term catalysts.
A move that holds above $57 on volume near the 9.9 million average, followed by a close above the $70 to $72 August high, would confirm the post-earnings trend. Targets beyond that sit at the $90 to $93 analyst zone. A break above $90 would shift focus to the $110 to $125 area.
Exit the trend setup on a weekly close below $55, and reduce exposure if Q3 guidance is not confirmed at the next earnings release in late October 2026.
If AXTI pulls back toward the $55 to $57 support or the $47 to $50 earnings-reaction base without a fundamental catalyst change, compare the pullback with export permit news, analyst commentary, and InP demand data before assuming the level holds. Mean-reversion trades in this name are high risk given 10-15% daily ranges.
Do not average down without a maximum loss rule, because small-cap semiconductor names can gap 20-30% on a single permit, customer, or index event.
Track quarterly InP revenue, gross margin versus the 45% Q2 level, backlog versus the $100 million plus level, customer prepayments, export permit approvals, share count versus 65 to 66 million, and Q3 to Q4 capacity milestones near $60 million quarterly by year-end.
Reduce or exit if margins compress below 30%, if permit delays hit the $66 million guided revenue, if backlog stalls, or if the company raises dilutive capital again after the April 2026 offering.
Investment research summary
AXT grows crystalline materials and sells InP, GaAs, and germanium substrate wafers that chipmakers use for data center optics, 5G, LiDAR, satellite solar, and consumer devices. Customers pay because substrate quality directly controls laser and detector performance in AI optical interconnects, and demand is currently outpacing supply.
The moat is technology- and qualification-driven. AXT combines crystal growth know-how, multi-year customer qualification cycles, an integrated supply chain with ten partially owned Chinese raw-material companies, and an estimated 40% share of InP substrates. Sumitomo, JX Nippon, and Chinese entrants could narrow this gap over time.
The thesis fails if InP demand slows, export permits block shipments, Chinese competitors erode share and pricing, gross margin falls back below 30%, the capacity ramp slips, or continued dilution offsets growth. The heaviest concentration is that nearly all wafer manufacturing sits in China with US export permits required for InP.
Founder-CEO Morris Young has led AXT since 1986. Recent decisions include an April 2026 equity raise of about $632 million gross to fund capacity, long-term supply agreements with Coherent, Lumentum, and Casela, and plans to roughly triple quarterly InP capacity by end-2026 and double it again in 2027. The raise funded growth but added about 50% more shares versus a year ago.
AXT sits at the center of AI infrastructure spending on optical connectivity. InP is a key enabler for 800G and 1.6T optical transceivers, and hyperscaler demand for faster, lower-power photonics is creating a secular tailwind. The industry is also cyclical, capital-intensive, and exposed to geopolitical shifts in the semiconductor supply chain.
At $68.67, AXTI trades near 36 times trailing revenue. The stock is about 52% below its high but still prices in a fast, sustained profit ramp. Margin of safety is thin; a wider buffer would need either a lower price or proof that the $60 million plus quarterly capacity run-rate converts into durable earnings.
Source-backed data
Every metric below includes a source and last verification date.
| Metric | Value | Source | Last verified |
|---|---|---|---|
| AXTI price | $68.67 (August 3, 2026 close); after-hours near $71 | Google Finance quote snapshot | August 3, 2026 |
| Market capitalization | $4.49 billion, verified as $68.67 x 65.42 million shares | financial_rigor.py market cap verification | August 3, 2026 |
| Shares outstanding | 65.42 million; Q3 guidance assumes about 66.5 million | Google Finance and AXT Q2 2026 release | August 3, 2026 |
| Q2 2026 results | $47.6 million revenue (+164.8% YoY), GAAP net income $11.1 million, GAAP diluted EPS $0.17 | AXT Q2 2026 earnings release (Business Wire) | July 30, 2026 |
| Q2 gross margin | 44.9% GAAP and 45.0% non-GAAP, versus 8.0% GAAP in Q2 2025 | AXT Q2 2026 earnings release (Business Wire) | July 30, 2026 |
| Q2 indium phosphide revenue | Record $30.7 million, driven by 800G and 1.6T optical transceiver demand | Zacks via Yahoo Finance | July 31, 2026 |
| Q3 2026 guidance | About $66 million revenue, non-GAAP EPS $0.30 to $0.32, GAAP EPS $0.29 to $0.31 | AXT Q2 2026 release and Zacks | July 30, 2026 |
| Backlog | Well above $100 million | AXT Q2 2026 earnings call summary | July 31, 2026 |
| Cash and investments | $748.8 million as of June 30, 2026, up from $123.2 million at March 31, 2026, after about $632 million gross from the April 2026 stock offering | Yahoo Finance key statistics and Zacks | July 31, 2026 |
| TTM revenue | $125.51 million | Yahoo Finance | August 3, 2026 |
| Analyst consensus | Average target near $91 (range $55 to $125); 4 Buy and 1 Hold ratings from 5 analysts | Google Finance and Yahoo Finance | August 3, 2026 |
| 52-week range | $1.90 to $143.16 | Google Finance and Yahoo Finance | August 3, 2026 |
| Technical snapshot | Beta 1.86 to 1.93, average volume near 9.9 million shares, August 3 volume 17.6 million | Google Finance and Yahoo Finance | August 3, 2026 |
This page is an informational research tool only and is not investment advice, financial advice, or a recommendation to buy or sell AXTI stock. Forecast scenarios are based on available public data, technical snapshots, and stated assumptions as of the data cutoff date and may be wrong. AXTI is a newly profitable, high-volatility small-cap stock with heavy China exposure. Always verify current filings, prices, export permit news, risks, and personal suitability before making financial decisions.
Design trading strategies visually with 10+ indicators. Set entry/exit conditions and risk management, then generate Pine Script code with no coding required.
Filter and discover stocks based on market cap, dividend yield, P/E ratio, sector, and more. Screen thousands of stocks with real-time data.
Smart AI-driven stock selection with fundamental screening, analyst estimates, and key metrics. Filter by P/E, market cap, dividends, and more.
